Arginine deprivation induces ROS dependent autophagic cell death in human acute myeloid leukemia cells.Other primary literatureHumanActiveHuman cell2026
Taki F, Farhat M, El-Atat O, et al.
Arginine restriction exploits DNMT3B-ASS1-driven arginine auxotrophy and mTORC1-suppressed autophagy to overcome niraparib resistance in ovarian cancer.Other primary literatureHuman & animalActiveCancer letters2026
Wang H, Wang X, Zhang W, et al.
Arginine deprivation enhances ASS1-negative glioblastoma radiosensitivity via epigenetic silencing of DNA repair genes.Other primary literatureUnknownActiveCell death & disease2026
Wu N, Xu Z, Perryman R, et al.
Arginine deprivation induces prolonged autophagy activation and ROS-dependent cell death in glioblastoma multiforme.Other primary literatureHumanActiveCNS oncology2026
Abdelkhalek M, El-Jawhari Y, Shaheen M, et al.
Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope Production.Other primary literatureHumanActiveCancer research2026
Nagel R, Kochavi A, Flem-Karlsen K, et al.
Overcoming resistance to arginine deprivation therapy using GC7 in pleural mesothelioma.Other primary literatureUnknownActiveiScience2025
Carpentier J, Freitas M, Morales V, et al.
Targeting AQP5-mediated arginine deprivation in gastric cancer stem cells restores NK cell anti-tumor immunity.Other primary literatureHuman & animalActiveCell reports. Medicine2025
Zhao R, He B, Huang L, et al.
Arginine Deprivation Induces Quiescence and Confers Vulnerability to Ferroptosis in Colorectal Cancer.Other primary literatureHuman & animalActiveCancer research2025
Lin Y, Zhang Y, Huang T, et al.
BCL-XL Protects ASS1-Deficient Cancers from Arginine Starvation-Induced Apoptosis.Other primary literatureHuman & animalActiveClinical cancer research : an official journal of the American Association for Cancer Research2025
Panda PK, Paschoalini Mafra AC, Bastos ACS, et al.
Etoposide-induced protein 2.4 homolog promotes argininosuccinate synthase 1 and cancer cell survival upon arginine deprivation.Other primary literatureHumanActiveCellular & molecular biology letters2025
Vo VTA, Tran LN, Bui TT, et al.
Adaptation to Arginine Deprivation Leads to a More Aggressive, Therapy-Resistant Phenotype in HNSCC Cells.Other primary literatureHumanActiveBiomolecules2025
Chen O, Vovk O, Polishchuk N, et al.
Inhibition of Tumor Microenvironment-Driven JAK-STAT Signaling Enhances Response to Arginine Deprivation Therapy in Triple-Negative Breast Cancer.Other primary literatureHuman & animalActiveCells2025
Tishler H, Ziman S, Cheng K, et al.
Arginine deprivation/citrulline augmentation with ADI-PEG20 as novel therapy for complications in type 2 diabetes.Other primary literatureAnimalActiveMolecular metabolism2024
Abdelrahman AA, Sandow PV, Wang J, et al.
Citrulline and ADI-PEG20 reduce inflammation in a juvenile porcine model of acute endotoxemia.Other primary literatureAnimalActiveFrontiers in immunology2024
Vonderohe C, Stoll B, Didelija I, et al.
Therapeutic potential of arginine deprivation therapy for gliomas: a systematic review of the existing literature.ReviewUnknownActiveFrontiers in pharmacology2024
Yuxiao C, Jiachen W, Yanjie L, et al.
Arginine deprivation enriches lung cancer proteomes with cysteine by inducing arginine-to-cysteine substitutants.Other primary literatureHumanActiveMolecular cell2024
Yang C, Pataskar A, Feng X, et al.
Oncogenic KRAS Induces Arginine Auxotrophy and Confers a Therapeutic Vulnerability to SLC7A1 Inhibition in Non-Small Cell Lung Cancer.Other primary literatureHuman & animalActiveCancer research2024
Gai X, Liu Y, Lan X, et al.
GCN2-SLC7A11 axis coordinates autophagy, cell cycle and apoptosis and regulates cell growth in retinoblastoma upon arginine deprivation.Other primary literatureUnknownActiveCancer & metabolism2024
Wang D, Chu WK, Yam JCS, et al.
Discovery and Targeting of a Noncanonical Mechanism of Sarcoma Resistance to ADI-PEG20 Mediated by the Microenvironment.Other primary literatureHuman & animalActiveClinical cancer research : an official journal of the American Association for Cancer Research2023
Rogers LC, Kremer JC, Brashears CB, et al.
A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma.Other primary literatureHuman & animalCorrectedPharmacological reports : PR2023
Phillips MM, Pavlyk I, Allen M, et al.
Arginine deprivation as a treatment approach targeting cancer cell metabolism and survival: A review of the literature.ReviewHumanActiveEuropean journal of pharmacology2023
Assi G, Faour WH
Unlocking the Potential of Arginine Deprivation Therapy: Recent Breakthroughs and Promising Future for Cancer Treatment.ReviewHumanActiveInternational journal of molecular sciences2023
Chu YD, Lai MW, Yeh CT
Bench-to-Bedside Studies of Arginine Deprivation in Cancer.ReviewHumanActiveMolecules (Basel, Switzerland)2023
Field GC, Pavlyk I, Szlosarek PW
A Phase 1 study of ADI-PEG20 (pegargiminase) combined with cisplatin and pemetrexed in ASS1-negative metastatic uveal melanoma.Other primary literatureHumanActivePigment cell & melanoma research2022
Chan PY, Phillips MM, Ellis S, et al.
Arginine deprivation alters microglial polarity and synergizes with radiation to eradicate non-arginine-auxotrophic glioblastoma tumors.Other primary literatureHumanActiveThe Journal of clinical investigation2022
Hajji N, Hajji N, Garcia-Revilla J, et al.
Creatine riboside is a cancer cell-derived metabolite associated with arginine auxotrophy.Other primary literatureHumanActiveThe Journal of clinical investigation2022
Parker AL, Toulabi L, Oike T, et al.
Arginine Deprivation in SCLC: Mechanisms and Perspectives for Therapy.ReviewUnknownActiveLung Cancer (Auckland, N.Z.)2022
Carpentier J, Pavlyk I, Mukherjee U, et al.
Preclinical evidence of a direct pro-survival role of arginine deprivation in multiple myeloma.Other primary literatureUnknownActiveFrontiers in oncology2022
Trudu M, Oliva L, Orfanelli U, et al.
Argininosuccinate synthase 1, arginine deprivation therapy and cancer management.ReviewUnknownActiveFrontiers in pharmacology2022
Sun N, Zhao X
Phase I study of ADI-PEG20 plus low-dose cytarabine for the treatment of acute myeloid leukemia.Other primary literatureHumanActiveCancer medicine2021
Tsai HJ, Hsiao HH, Hsu YT, et al.
Indospicine combined with arginine deprivation triggers cancer cell death via caspase-dependent apoptosis.Other primary literatureHumanActiveCell biology international2021
Shuvayeva GY, Bobak YP, Vovk OI, et al.
Activation of autophagy following [HuArgI (Co)-PEG5000]-induced arginine deprivation mediates cell death in colon cancer cells.Other primary literatureHumanActiveHuman cell2021
Swayden M, Bekdash A, Fakhoury I, et al.
Arginine deprivation as a strategy for cancer therapy: An insight into drug design and drug combination.ReviewHuman & animalActiveCancer letters2021
Zhang Y, Chung SF, Tam SY, et al.
Chromatin accessibility governs the differential response of cancer and T cells to arginine starvation.Other primary literatureHuman & animalActiveCell reports2021
Crump NT, Hadjinicolaou AV, Xia M, et al.
Phase 1 trial of ADI-PEG20 plus cisplatin in patients with pretreated metastatic melanoma or other advanced solid malignancies.Other primary literatureHumanActiveBritish journal of cancer2021
Yao S, Janku F, Subbiah V, et al.
NEI-01-Induced Arginine Deprivation Has Potent Activity Against Acute Myeloid Leukemia Cells Both In Vitro and In Vivo.Other primary literatureHuman & animalActiveMolecular cancer therapeutics2021
Cai Y, Chow JPH, Leung YO, et al.
Intracellular arginine-dependent translation sensor reveals the dynamics of arginine starvation response and resistance in ASS1-negative cells.Other primary literatureUnknownActiveCancer & metabolism2021
Rogers LC, Zhou J, Baker A, et al.
A Co-Culture Model of IPEC-J2 and Swine PBMC to Study the Responsiveness of Intestinal Epithelial Cells: The Regulatory Effect of Arginine Deprivation.Other primary literatureUnknownActiveAnimals : an open access journal from MDPI2021
Saleri R, Borghetti P, Ravanetti F, et al.
Expansion of Myeloid Derived Suppressor Cells Contributes to Platelet Activation by L-Arginine Deprivation during SARS-CoV-2 Infection.Other primary literatureHumanActiveCells2021
Sacchi A, Grassi G, Notari S, et al.
Enhancing the Effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Signaling and Arginine Deprivation in Melanoma.ReviewHumanActiveInternational journal of molecular sciences2021
Wu C, You M, Nguyen D, et al.
Arginine starvation elicits chromatin leakage and cGAS-STING activation via epigenetic silencing of metabolic and DNA-repair genes.Other primary literatureHumanActiveTheranostics2021
Hsu SC, Chen CL, Cheng ML, et al.
Cytotoxicity of [HuArgI (co)-PEG5000]-induced arginine deprivation to ovarian Cancer cells is autophagy dependent.Other primary literatureHumanActiveInvestigational new drugs2020
Nasreddine G, El-Sibai M, Abi-Habib RJ
[HuArgI (co)-PEG5000]-induced arginine deprivation leads to autophagy dependent cell death in pancreatic cancer cells.Other primary literatureHumanActiveInvestigational new drugs2020
Khalil N, Abi-Habib RJ
Arginine deprivation inhibits pancreatic cancer cell migration, invasion and EMT via the down regulation of Snail, Slug, Twist, and MMP1/9.Other primary literatureHuman & animalActiveJournal of physiology and biochemistry2020
Wang H, Li QF, Chow HY, et al.
Phase II Study of Arginine Deprivation Therapy With Pegargiminase in Patients With Relapsed Sensitive or Refractory Small-cell Lung Cancer.Other primary literatureHumanActiveClinical lung cancer2020
Hall PE, Ready N, Johnston A, et al.
Collaboration Between RSK-EphA2 and Gas6-Axl RTK Signaling in Arginine Starvation Response That Confers Resistance to EGFR Inhibitors.Other primary literatureUnknownActiveTranslational oncology2020
Kuo MT, Long Y, Tsai WB, et al.
Systems level profiling of arginine starvation reveals MYC and ERK adaptive metabolic reprogramming.Other primary literatureHumanActiveCell death & disease2020
Brashears CB, Barlin M, Ehrhardt WR, et al.
Selective extracellular arginine deprivation by a single injection of cellular non-uptake arginine deiminase nanocapsules for sustained tumor inhibition.Other primary literatureAnimalActiveNanoscale2020
Qi H
, Wang Y
, Yuan X
, et al.
MicroRNA-1291-5p Sensitizes Pancreatic Carcinoma Cells to Arginine Deprivation and Chemotherapy through the Regulation of Arginolysis and Glycolysis.Other primary literatureHumanActiveMolecular pharmacology2020
Tu MJ, Duan Z, Liu Z, et al.
Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase-Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic Type.Other primary literatureHuman & animalActiveClinical cancer research : an official journal of the American Association for Cancer Research2020
Ji JX, Cochrane DR, Tessier-Cloutier B, et al.
Arginine deprivation: a potential therapeutic for cancer cell metastasis? A review.ReviewUnknownActiveCancer cell international2020
Al-Koussa H, El Mais N, Maalouf H, et al.
Combinatory Treatment of Canavanine and Arginine Deprivation Efficiently Targets Human Glioblastoma Cells via Pleiotropic Mechanisms.Other primary literatureHuman & animalActiveCells2020
Karatsai O, Shliaha P, Jensen ON, et al.
Histone deacetylase inhibition is synthetically lethal with arginine deprivation in pancreatic cancers with low argininosuccinate synthetase 1 expression.Other primary literatureHuman & animalActiveTheranostics2020
Kim SS, Xu S, Cui J, et al.
Arginine Starvation and Docetaxel Induce c-Myc-Driven hENT1 Surface Expression to Overcome Gemcitabine Resistance in ASS1-Negative Tumors.Other primary literatureHuman & animalActiveClinical cancer research : an official journal of the American Association for Cancer Research2019
Prudner BC, Rathore R, Robinson AM, et al.
Exploiting Arginine Auxotrophy with Pegylated Arginine Deiminase (ADI-PEG20) to Sensitize Pancreatic Cancer to Radiotherapy via Metabolic Dysregulation.Other primary literatureHuman & animalActiveMolecular cancer therapeutics2019
Singh PK, Deorukhkar AA, Venkatesulu BP, et al.
Innate and adaptive resistance mechanisms to arginine deprivation therapies in sarcoma and other cancers.ReviewUnknownActiveCancer drug resistance (Alhambra, Calif.)2019
Rogers LC, Van Tine BA
Efficacy of arginine depletion by ADI-PEG20 in an intracranial model of GBM.Other primary literatureHuman & animalActiveCell death & disease2018
Przystal JM, Hajji N, Khozoie C, et al.
Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes.Other primary literatureHuman & animalActiveScientific reports2018
Alexandrou C, Al-Aqbi SS, Higgins JA, et al.
Arginine starvation kills tumor cells through aspartate exhaustion and mitochondrial dysfunction.Other primary literatureUnknownActiveCommunications biology2018
Cheng CT, Qi Y, Wang YC, et al.
Arginine Deprivation Therapy: Putative Strategy to Eradicate Glioblastoma Cells by Radiosensitization.Other primary literatureHumanActiveMolecular cancer therapeutics2018
Hinrichs CN, Ingargiola M, Käubler T, et al.
Decreased argininosuccinate synthetase expression in Thai patients with cholangiocarcinoma and the effects of ADI-PEG20 treatment in CCA cell lines.Other primary literatureUnknownActiveOncology letters2018
Roeksomtawin S, Navasumrit P, Waraprasit S, et al.
Amino Acid Uptake Measured by [18F]AFETP Increases in Response to Arginine Starvation in ASS1-Deficient Sarcomas.Other primary literatureHumanActiveTheranostics2018
Prudner BC, Sun F, Kremer JC, et al.
Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1-Deficient Malignant Pleural Mesothelioma: A Randomized Clinical Trial.Randomized controlled trialHumanActiveJAMA oncology2017
Szlosarek PW, Steele JP, Nolan L, et al.
Degradation of AMPK-α1 sensitizes BRAF inhibitor-resistant melanoma cells to arginine deprivation.Other primary literatureHuman & animalActiveMolecular oncology2017
Li YY, Wu C, Shah SS, et al.
Construction and in vitro evaluation of enzyme nanoreactors based on carboxymethyl chitosan for arginine deprivation in cancer therapy.Other primary literatureUnknownActiveCarbohydrate polymers2017
Zeng T, Zhang Y, Yan Q, et al.
Arginine Deprivation Inhibits the Warburg Effect and Upregulates Glutamine Anaplerosis and Serine Biosynthesis in ASS1-Deficient Cancers.Other primary literatureHuman & animalActiveCell reports2017
Kremer JC, Prudner BC, Lange SES, et al.
Nitric oxide donor augments antineoplastic effects of arginine deprivation in human melanoma cells.Other primary literatureHumanActiveExperimental cell research2017
Mayevska O, Chen O, Karatsai O, et al.
A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients.Other primary literatureHumanActiveScientific reports2017
Tsai HJ, Jiang SS, Hung WC, et al.
Chromatin remodeling system p300-HDAC2-Sin3A is involved in Arginine Starvation-Induced HIF-1α Degradation at the ASS1 promoter for ASS1 Derepression.Other primary literatureHumanActiveScientific reports2017
Tsai WB, Long Y, Chang JT, et al.
Therapeutic arginine starvation in ASS1-deficient cancers inhibits the Warburg effect.Other primary literatureUnknownActiveMolecular & cellular oncology2017
Kremer JC, Van Tine BA
The Combination of Arginine Deprivation and 5-Fluorouracil Improves Therapeutic Efficacy in Argininosuccinate Synthetase Negative Hepatocellular Carcinoma.Other primary literatureHumanActiveInternational journal of molecular sciences2017
Thongkum A, Wu C, Li YY, et al.
Co-application of canavanine and irradiation uncouples anticancer potential of arginine deprivation from citrulline availability.Other primary literatureHumanActiveOncotarget2016
Kurlishchuk Y, Vynnytska-Myronovska B, Grosse-Gehling P, et al.
Arginine deprivation induces endoplasmic reticulum stress in human solid cancer cells.Other primary literatureHumanActiveThe international journal of biochemistry & cell biology2016
Bobak Y, Kurlishchuk Y, Vynnytska-Myronovska B, et al.
Arginine starvation in colorectal carcinoma cells: Sensing, impact on translation control and cell cycle distribution.Other primary literatureHumanActiveExperimental cell research2016
Vynnytska-Myronovska BO, Kurlishchuk Y, Chen O, et al.
A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomas.Other primary literatureHumanActiveCell death & disease2016
Bean GR, Kremer JC, Prudner BC, et al.
Hypoxia-induced nitric oxide production and tumour perfusion is inhibited by pegylated arginine deiminase (ADI-PEG20).Other primary literatureHuman & animalActiveScientific reports2016
Burrows N, Cane G, Robson M, et al.
BRAF inhibitor resistance enhances vulnerability to arginine deprivation in melanoma.Other primary literatureHuman & animalActiveOncotarget2016
Li YY, Wu C, Chen SM, et al.
Arginine deprivation affects glioblastoma cell adhesion, invasiveness and actin cytoskeleton organization by impairment of β-actin arginylation.Other primary literatureHumanActiveAmino acids2015
Pavlyk I, Rzhepetskyy Y, Jagielski AK, et al.
Arginine deprivation by arginine deiminase of Streptococcus pyogenes controls primary glioblastoma growth in vitro and in vivo.Other primary literatureHuman & animalActiveCancer biology & therapy2015
Fiedler T, Strauss M, Hering S, et al.
Arginine deprivation in cancer therapy.ReviewHumanActiveCurrent opinion in clinical nutrition and metabolic care2015
Feun LG, Kuo MT, Savaraj N
Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors.Other primary literatureHumanActiveClinical cancer research : an official journal of the American Association for Cancer Research2015
Tomlinson BK, Thomson JA, Bomalaski JS, et al.
Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in vivo.Other primary literatureHuman & animalActiveBlood2015
Miraki-Moud F, Ghazaly E, Ariza-McNaughton L, et al.
Arginine starvation impairs mitochondrial respiratory function in ASS1-deficient breast cancer cells.Other primary literatureHuman & animalActiveScience signaling2014
Qiu F, Chen YR, Liu X, et al.
Arginine starvation-associated atypical cellular death involves mitochondrial dysfunction, nuclear DNA leakage, and chromatin autophagy.Other primary literatureHumanActiveProceedings of the National Academy of Sciences of the United States of America2014
Changou CA, Chen YR, Xing L, et al.
Arginine deprivation and autophagic cell death in cancer.Other primary literatureHumanActiveProceedings of the National Academy of Sciences of the United States of America2014
Szlosarek PW
Single amino acid arginine deprivation triggers prosurvival autophagic response in ovarian carcinoma SKOV3.Other primary literatureHumanActiveBioMed research international2014
Shuvayeva G, Shuvayeva G, Bobak Y, et al.
Combination of arginine deprivation with TRAIL treatment as a targeted-therapy for mesothelioma.Other primary literatureHumanActiveAnticancer research2014
Wangpaichitr M, Wu C, Bigford G, et al.
TRAIL induces autophagic protein cleavage through caspase activation in melanoma cell lines under arginine deprivation.Other primary literatureHumanActiveMolecular and cellular biochemistry2013
You M, Savaraj N, Kuo MT, et al.
Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation.Other primary literatureAnimalActivePloS one2013
Wells JW, Evans CH, Scott MC, et al.
Arginine deprivation therapy for malignant melanoma.Other primary literatureUnknownActiveClinical pharmacology : advances and applications2013
Yoon JK, Frankel AE, Feun LG, et al.
Single amino acid arginine starvation efficiently sensitizes cancer cells to canavanine treatment and irradiation.Other primary literatureHumanActiveInternational journal of cancer2012
Vynnytska-Myronovska B, Bobak Y, Garbe Y, et al.
Arginine deprivation as a new treatment strategy for head and neck cancer.Other primary literatureHumanActiveOral oncology2012
Huang CC, Tsai ST, Kuo CC, et al.
Nutritional stress and arginine auxotrophy confer high sensitivity to chloroquine toxicity in mesothelioma cells.Other primary literatureHumanActiveAmerican journal of respiratory cell and molecular biology2012
Battisti S, Valente D, Albonici L, et al.
Canavanine augments proapoptotic effects of arginine deprivation in cultured human cancer cells.Other primary literatureHumanActiveAnti-cancer drugs2011
Vynnytska BO, Mayevska OM, Kurlishchuk YV, et al.
Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer.ReviewHuman & animalActiveInternational journal of cancer2010
Delage B, Fennell DA, Nicholson L, et al.
The combination of ADI-PEG20 and TRAIL effectively increases cell death in melanoma cell lines.Other primary literatureHumanActiveBiochemical and biophysical research communications2010
You M, Savaraj N, Wangpaichitr M, et al.
Cancer cell sensitivity to arginine deprivation in vitro is not determined by endogenous levels of arginine metabolic enzymes.Other primary literatureHumanActiveCell biology international2010
Bobak YP, Vynnytska BO, Kurlishchuk YV, et al.
Arginine deprivation, autophagy, apoptosis (AAA) for the treatment of melanoma.ReviewHumanActiveCurrent molecular medicine2010
Savaraj N, You M, Wu C, et al.
L-arginine deprivation regulates cyclin D3 mRNA stability in human T cells by controlling HuR expression.Other primary literatureHumanActiveJournal of immunology (Baltimore, Md. : 1950)2010
Rodriguez PC, Hernandez CP, Morrow K, et al.
L-arginine deprivation impairs Leishmania major-specific T-cell responses.Other primary literatureAnimalActiveEuropean journal of immunology2009
Munder M, Choi BS, Rogers M, et al.
Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer.Other primary literatureHumanActiveInternational journal of cancer2009
Nicholson LJ, Smith PR, Hiller L, et al.
Differential impact of L-arginine deprivation on the activation and effector functions of T cells and macrophages.Other primary literatureAnimalActiveJournal of leukocyte biology2009
Choi BS, Martinez-Falero IC, Corset C, et al.
Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase.Other primary literatureHuman & animalActiveInternational journal of cancer2008
Bowles TL, Kim R, Galante J, et al.
Arginine deprivation as a targeted therapy for cancer.ReviewHuman & animalActiveCurrent pharmaceutical design2008
Feun L, You M, Wu CJ, et al.
Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase.Other primary literatureHuman & animalActiveInternational journal of cancer2007
Yoon CY, Shim YJ, Kim EH, et al.
Anti-tumor activity of arginine deiminase via arginine deprivation in retinoblastoma.Other primary literatureHumanActiveOncology reports2007
Kim JH, Kim JH, Yu YS, et al.
The relationship of arginine deprivation, argininosuccinate synthetase and cell death in melanoma.Other primary literatureUnknownActiveDrug target insights2007
Savaraj N, Wu C, Kuo MT, et al.
Arginine deprivation and metabolomics: important aspects of intermediary metabolism in relation to the differential sensitivity of normal and tumour cells.ReviewHumanActiveSeminars in cancer biology2005
Wheatley DN
Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivation.Other primary literatureHumanActiveCancer2004
Dillon BJ, Prieto VG, Curley SA, et al.
Arginine deprivation, growth inhibition and tumour cell death: 3. Deficient utilisation of citrulline by malignant cells.Other primary literatureHumanActiveBritish journal of cancer2003
Wheatley DN, Campbell E
Arginine deprivation and tumour cell death: arginase and its inhibition.Other primary literatureHuman & animalActiveMolecular and cellular biochemistry2003
Wheatley DN, Philip R, Campbell E
Arginine deprivation, growth inhibition and tumour cell death: 2. Enzymatic degradation of arginine in normal and malignant cell cultures.Other primary literatureHuman & animalActiveBritish journal of cancer2003
Philip R, Campbell E, Wheatley DN
Macrophage function in response to PGE2, L-arginine deprivation, and activation by colony-stimulating factors is dependent on hematopoietic stimulus.Other primary literatureAnimalActiveJournal of leukocyte biology1992
Rutherford MS, Schook LB
The influence of arginine starvation on the synthesis of virus high molecular weight DNA in HeLa cells productively infected by adenovirus type 5.Other primary literatureHumanActiveThe Journal of general virology1979
Kümel G, Hammer HJ
Arginine deprivation in KB cells. II. Characterization of the DNA synthesized during starvation.Other primary literatureUnknownActiveThe Journal of cell biology1977
Weissfeld AS, Rouse H
Effect of arginine starvation on macromolecular synthesis in infection with type 2 adenovirus. II. Synthesis of virus-specific RNA and DNA.Other primary literatureHumanActiveVirology1972
Raska K Jr, Prage L, Schlesinger RW
Reverse transcriptase-containing particles induced in rous sarcoma virus-transformed rat cells by arginine deprivation.Other primary literatureAnimalActiveJournal of virology1972
Kotler M, Weinberg E, Haspel O, et al.
Effects of arginine deprivation, ultraviolet radiation, and x-radiation on cultured KB cells. A cytochemical and ultrastructural study.Other primary literatureHumanActiveThe Journal of cell biology1965
Lane NJ, Novikoff AB
Arginine depletion through ADI-PEG20 to treat argininosuccinate synthase deficient ovarian cancer, including small cell carcinoma of the ovary, hypercalcemic typeDesign not determinedUnknownUnknown
Ji JX, Cochrane DR, Tessier-Cloutier B, et al.
Arginine deprivation and cancer in vitro and in vivo investigationsDesign not determinedUnknownUnknown
Scott LA
Arginine deprivation therapy : tumour cell rescueDesign not determinedUnknownUnknown
Campbell E
The role of the tumour microenvironment in arginine deprivation in malignant pleural mesotheliomaDesign not determinedUnknownUnknown
Phillips M
Targeting arginine auxotrophy in colorectal cancerDesign not determinedUnknownUnknown
Alexandrou C
METHODS FOR PREDICTING SENSITIVITY OF TUMORS TO ARGININE DEPRIVATIONDesign not determinedUnknownUnknown
CLARK Mike A., ENSOR Charles Mark, HOLTSBERG Frederick Wayne
Methods for predicting sensitivity of tumors to arginine deprivationDesign not determinedUnknownUnknown
CLARK MIKE A, ENSOR CHARLES MARK, HOLTSBERG FREDERICK WAYNE
METHODS FOR PREDICTING SENSITIVITY OF TUMORS TO ARGININE DEPRIVATIONDesign not determinedUnknownUnknown
CLARK Mike A., ENSOR Charles Mark, HOLTSBERG Frederick Wayne